These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37894850)

  • 21. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
    Kang S; Tanaka T; Inoue H; Ono C; Hashimoto S; Kioi Y; Matsumoto H; Matsuura H; Matsubara T; Shimizu K; Ogura H; Matsuura Y; Kishimoto T
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22351-22356. PubMed ID: 32826331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Controversial Role of LPS in Platelet Activation In Vitro.
    Galgano L; Guidetti GF; Torti M; Canobbio I
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction.
    Cao C; Chai Y; Shou S; Wang J; Huang Y; Ma T
    Int Immunopharmacol; 2018 Jan; 54():169-176. PubMed ID: 29149705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC
    Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
    Conte C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
    Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
    J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotoxin recognition molecules MD-2 and toll-like receptor 4 as potential targets for therapeutic intervention of endotoxin shock.
    Miyake K
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):291-7. PubMed ID: 15379597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases.
    Leon CG; Tory R; Jia J; Sivak O; Wasan KM
    Pharm Res; 2008 Aug; 25(8):1751-61. PubMed ID: 18493843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor 4: A promising therapeutic target for pneumonia caused by Gram-negative bacteria.
    Ding J; Liu Q
    J Cell Mol Med; 2019 Sep; 23(9):5868-5875. PubMed ID: 31350813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endotoxin (LPS) in the pathogenesis of atherosclerosis].
    Konev IuV; Lazebnik LB
    Eksp Klin Gastroenterol; 2011; (11):15-26. PubMed ID: 22629714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial responses to endotoxins and Gram-negative bacteria.
    Heumann D; Roger T
    Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.
    Giordano NP; Cian MB; Dalebroux ZD
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32253250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Xu K; Wei Y; Giunta S; Zhou M; Xia S
    Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4.
    Roger T; Froidevaux C; Le Roy D; Reymond MK; Chanson AL; Mauri D; Burns K; Riederer BM; Akira S; Calandra T
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2348-52. PubMed ID: 19181857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock.
    Ramos-Benitez MJ; Ruiz-Jimenez C; Rosado-Franco JJ; Ramos-Pérez WD; Mendez LB; Osuna A; Espino AM
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30567900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis.
    Alarcón-Vila C; Baroja-Mazo A; de Torre-Minguela C; Martínez CM; Martínez-García JJ; Martínez-Banaclocha H; García-Palenciano C; Pelegrin P
    Elife; 2020 Nov; 9():. PubMed ID: 33135636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding Toll-like receptor 4.
    Foit L; Thaxton CS
    Biomaterials; 2016 Sep; 100():67-75. PubMed ID: 27244690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.